Resources

2 Resources for

chroma therapeutics

The BIA has also recently appointed a number of new board directors: Ian Nicholson, ceo of Chroma Therapeutics; Steve Chatfield, ceo of Emergent Europe; Andrew Heath, ceo of Protherics; Andy Richards, non-executive director of Vectura; and Simon Sturge, c: The BIA has also recently appointed a number of new board directors: Ian Nicholson, ceo of Chroma Therapeutics; Steve Chatfield, ceo of Emergent Europe; Andrew Heath, ceo of Protherics; Andy Richards, non-executive director of Vectura; and Simon Sturge, ceo of Vernalis. Directors are appointed for a period of two years...; Tags: Protherics Plc.; Research articles 2005-11-21
Invitrogen and Chroma Therapeutics Extend Kinase Screening Partnership: Kinase Drug Discovery Program Will Utilize Invitrogen's SelectScreen[TM] Platform; Tags: Invitrogen Corp.; Research articles 2008-02-25